AC
CHRS icon

Athanor Capital’s Coherus Oncology CHRS Stock Holding History

Athanor Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,273
Closed -$194K – 494
2021
Q1 		$194K Sell
13,273
-18,527
-58% -$315K ﹤0.01% 740
2020
Q4 		$553K Sell
31,800
-3,210
-9% -$57.2K 0.01% 443
2020
Q3 		$642K Buy
35,010
+3,418
+11% +$63.6K 0.02% 294
2020
Q2 		$564K Buy
+31,592
New +$535K 0.03% 285

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Athanor Capital's CHRS Position: Q2 2021 in Review

Athanor Capital sold out of Coherus Oncology (CHRS) in Q2 2021, closing a stake of 13,273 shares — an estimated $194K sold.

Athanor Capital first reported a position in CHRS in Q2 2020 and held it in 4 quarters. The position peaked at $642K in Q3 2020. 188 funds tracked by Wall St. Rank hold CHRS as of Q2 2021.

  • Athanor Capital reported no remaining Coherus Oncology position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 13,273 Coherus Oncology shares in Q2 2021, an estimated $194K.
  • Athanor Capital first reported a position in Coherus Oncology in Q2 2020 and held it in 4 quarters.
  • Athanor Capital's Coherus Oncology position peaked at $642K in Q3 2020.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.